2024/07/17 17:30:08 | |
---|---|
Price | |
45.50 CHF | |
Difference | -2.36% (-1.10) |
ISIN | CH0025343259 |
Symbol | CLTN |
Exchange | SIX Swiss Exchange |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 279 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 45.30 CHF (1) |
Ask (Ask size) | 45.50 CHF (127) |
Open | 46.80 CHF |
High | 46.80 CHF |
Low | 44.80 CHF |
Close (prev. day) | 46.60 CHF |
VWAP | 45.458193 CHF |
Volume (pcs) | 6,829 |
Trading volume | 310,434.00 |
Number of trades | 259 |
Last size | 40 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/03 |
![]() |
Global Strategy 3Q 2024 |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/03/26 |
![]() |
Global Strategy 2Q 2024 |
![]() |
2024/02/22 |
![]() |
Global Equity Ratings |
![]() |
2024/07/17 17:30:08 | |
---|---|
Price | |
45.50 CHF | |
Difference | -2.36% (-1.10) |
ISIN | CH0025343259 |
Symbol | CLTN |
Exchange | SIX Swiss Exchange |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 279 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 45.30 CHF (1) |
Ask (Ask size) | 45.50 CHF (127) |
Open | 46.80 CHF |
High | 46.80 CHF |
Low | 44.80 CHF |
Close (prev. day) | 46.60 CHF |
VWAP | 45.458193 CHF |
Volume (pcs) | 6,829 |
Trading volume | 310,434.00 |
Number of trades | 259 |
Last size | 40 |
6m | 1Y | 3Y | |
Perf (%) | -31.68% | -34.06% | -61.89% |
Perf (abs.) | -21.10 | -23.50 | -73.90 |
Beta | 0.49 | 0.56 | 0.78 |
Volatility | 30.31 | 31.82 | 33.66 |
Ø price 5 days | Ø volume 5 days (pcs.) | 47.08 CHF (2,792) |
Ø price 30 days | Ø volume 30 days (pcs.) | 48.58 CHF (4,177) |
Ø price 100 days | Ø volume 100 days (pcs.) | 52.79 CHF (5,596) |
Ø price 250 days | Ø volume 250 days (pcs.) | 60.54 CHF (3,686) |
YTD High | date | 70.90 CHF (2024/01/03) |
YTD Low | date | 44.80 CHF (2024/07/17) |
52 Weeks High | date | 72.40 CHF (2023/12/29) |
52 Weeks Low | date | 44.80 CHF (2024/07/17) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
SIX Swiss Exchange | 2024/07/17 | 17:30 | 45.50 CHF | 0.31 | 259 |
London Stock Exchange | 2023/09/29 | 17:36 | 66.50 CHF | 0.02 | 1 |
Frankfurt | 2019/06/28 | 13:24 | 78.00 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/02/29 | 21:10 | 61.16 USD | 0.01 | 1 |
COLTENE HOLDING AG |
- - |
Feldwiesenstrasse 20 - 9450 Altstätten |
Telefon: +41-71-757-53-80 |
Fax: +41-71-757-53-01 |
E-mail: info.ch@coltene.com |
Coltene Holding AG is engaged in the development, production, and sale of tools and equipment of dental consumables. Its products include adhesives, restoratives, endodontics, prosthetics, rotary instruments, treatment auxiliaries, laboratory, and infection control. The company was founded on December 15, 2005 and is headquartered in Altstatten, Switzerland. |
Dominik Arnold | Chairman of Managing Board |
Martin Schlüter | Member of Executive Committee |
Werner Barth | Member of Executive Committee |
Di Hu | Member of Executive Committee |
Gregor Picard | Member of Executive Committee |
Markus Abderhalden | Member of Executive Committee |
Paul Frey | Member of Executive Committee |
Allison Zwingenberger | Member of the administrative board |
Astrid Waser | Member of the administrative board |
Daniel Bühler | Member of the administrative board |
Roland Weiger | Member of the administrative board |
Jürgen Rauch | Member of the administrative board |
Matthias Altendorf | Member of the administrative board |
Nick Huber | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer